Allworth Financial LP Has $109,000 Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Allworth Financial LP increased its position in DocuSign, Inc. (NASDAQ:DOCU) by 283.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,833 shares of the company’s stock after buying an additional 1,355 shares during the period. Allworth Financial LP’s holdings in DocuSign were worth $109,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of DocuSign by 2.4% in the 3rd quarter. Vanguard Group Inc. now owns 20,982,387 shares of the company’s stock valued at $881,260,000 after buying an additional 482,472 shares during the period. Capital World Investors grew its stake in shares of DocuSign by 128.3% in the 1st quarter. Capital World Investors now owns 5,683,838 shares of the company’s stock valued at $608,853,000 after buying an additional 3,193,727 shares during the period. Morgan Stanley grew its stake in shares of DocuSign by 1.7% in the 3rd quarter. Morgan Stanley now owns 3,219,450 shares of the company’s stock valued at $135,217,000 after buying an additional 53,553 shares during the period. Clearbridge Investments LLC grew its stake in shares of DocuSign by 1.9% in the 1st quarter. Clearbridge Investments LLC now owns 3,186,783 shares of the company’s stock valued at $341,368,000 after buying an additional 58,555 shares during the period. Finally, Renaissance Technologies LLC grew its stake in shares of DocuSign by 0.3% in the 1st quarter. Renaissance Technologies LLC now owns 2,872,900 shares of the company’s stock valued at $167,490,000 after buying an additional 8,300 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

DocuSign Stock Down 1.0 %

DocuSign stock opened at $58.90 on Friday. DocuSign, Inc. has a 52 week low of $38.11 and a 52 week high of $64.76. The company’s 50 day moving average price is $55.37 and its two-hundred day moving average price is $51.59. The stock has a market cap of $12.10 billion, a P/E ratio of 163.62, a P/E/G ratio of 5.18 and a beta of 0.89.

DocuSign (NASDAQ:DOCU) last posted its earnings results on Thursday, March 7th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.09 by $0.06. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. The firm had revenue of $712.39 million for the quarter, compared to analysts’ expectations of $698.05 million. On average, equities analysts anticipate that DocuSign, Inc. will post 0.86 EPS for the current year.

Insider Buying and Selling

In related news, Director Teresa Briggs sold 499 shares of DocuSign stock in a transaction that occurred on Thursday, February 29th. The shares were sold at an average price of $52.99, for a total value of $26,442.01. Following the sale, the director now owns 6,169 shares of the company’s stock, valued at approximately $326,895.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Teresa Briggs sold 499 shares of DocuSign stock in a transaction that occurred on Thursday, February 29th. The shares were sold at an average price of $52.99, for a total value of $26,442.01. Following the sale, the director now owns 6,169 shares of the company’s stock, valued at approximately $326,895.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Peter Solvik sold 15,000 shares of DocuSign stock in a transaction that occurred on Tuesday, April 9th. The stock was sold at an average price of $60.00, for a total transaction of $900,000.00. Following the completion of the sale, the director now directly owns 783 shares in the company, valued at approximately $46,980. The disclosure for this sale can be found here. In the last quarter, insiders have sold 54,871 shares of company stock valued at $3,176,199. 17.80% of the stock is owned by company insiders.

Analyst Ratings Changes

Several brokerages recently weighed in on DOCU. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $59.00 price target on shares of DocuSign in a research report on Friday. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Friday. UBS Group raised shares of DocuSign from a “sell” rating to a “neutral” rating and raised their price target for the company from $48.00 to $62.00 in a research report on Friday. Morgan Stanley raised shares of DocuSign from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $49.00 to $64.00 in a research report on Tuesday, January 16th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $84.00 price target on shares of DocuSign in a research report on Friday. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, DocuSign presently has an average rating of “Hold” and an average target price of $60.25.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.